 CAMBRIDGE, Mass., June 11, 2021 GLOBE NEWSWIRE -- Vor Biopharma Nasdaq: VOR or the Company, a cell therapy company pioneering engineered hematopoietic stem cell eHSC therapies to be used in combination with targeted therapies for the treatment of cancer, today announced Matthew R. Patterson as Chairman of its Board of Directors. 